SCHEMBL6182941

SCHEMBL6182941

CCCc1ccc(C(C)CN)cc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.54
HTR2A P28223 2/20 0.46
CA2 P00918 1/20 0.42
LPL P06858 1/20 0.41
LIPG Q9Y5X9 1/20 0.41
ACACB O00763 2/20 0.41
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
KMT2A Q03164 1/20 0.38
ACACA Q13085 1/20 0.38
SIGMAR1 Q99720 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8637549 0.88 HTR2A (0.56) TAAR1HTR2ACA2ESR1KDM4E
SCHEMBL7639716 0.85 HTR2A (0.66) TAAR1HTR2ACA2LPLLIPG
SCHEMBL20036657 0.83 LPL (0.43) CA2LPLLIPGACACBESR1
SCHEMBL3006604 0.82 TAAR1 (0.75) TAAR1HTR2AESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL6564727 0.79 TAAR1 (0.71) TAAR1HTR2AESR1ESR2KDM4E
SCHEMBL10130853 0.79 LPL (0.45) CA2LPLLIPGACACBESR1
SCHEMBL14873127 0.79 HTR2A (0.46) TAAR1HTR2ACA2LPLLIPG
SCHEMBL4796978 0.78 ADRB2 (0.48) TAAR1HTR2ACA2LPLLIPG
SCHEMBL7043601 0.78 ADRB2 (0.48) TAAR1HTR2ACA2LPLLIPG
Hydrochloric Acid SCHEMBL27512774 0.78 TAAR1 (0.58) TAAR1CA2ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1529038-A1 BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY Novartis AG (CH) 2005-05-11 EP disclosed
WO-2004016601-A1 BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY NOVARTIS AG (CH) 2004-02-26 WO disclosed